Results of early panretinal laser coagulation in patients with type 1 diabetes mellitus

Aim. To evaluate results of panretinal laser coagulation (PLC) for severe non-proliferative and early proliferetaive diabetic retinopathy (DR) in patientswith type 1 diabetes mellitus (DM1). Materials and methods. 58 patients with DM1 were observed. All of them were treated by panretinal laser coa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dmitriy Sergeevich Atarshchikov, Vladimir Yur'evich Evgrafov, Yury Evgen'evich Batmanov
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2010
Materias:
Acceso en línea:https://doaj.org/article/45340d6bf79e49b5b1900d5b2ff1185a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:45340d6bf79e49b5b1900d5b2ff1185a
record_format dspace
spelling oai:doaj.org-article:45340d6bf79e49b5b1900d5b2ff1185a2021-11-14T09:00:14ZResults of early panretinal laser coagulation in patients with type 1 diabetes mellitus2072-03512072-037810.14341/2072-0351-6025https://doaj.org/article/45340d6bf79e49b5b1900d5b2ff1185a2010-03-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/6025https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Aim. To evaluate results of panretinal laser coagulation (PLC) for severe non-proliferative and early proliferetaive diabetic retinopathy (DR) in patientswith type 1 diabetes mellitus (DM1). Materials and methods. 58 patients with DM1 were observed. All of them were treated by panretinal laser coagulation after subtenon administrationof triamcinolone (40 mg) under ultrasonic control. Results. PLC at the stage of severe non-proliferative DR stabilized its development in 35% of the patients and caused its reverse development withresolution of oedema and intraretinal hemorrhage, normalization of vein diameter, and improvement of visual acuity in 30%. In 35% of these casesPLC caused neovascularization within 1.6?0.9 years after treatment. Reverse development of DR after PLC was documented in 46.3% cases withearly proliferative DR but stabilization of DR occurred rarer than in the previous group (14.6%) and hemorrhage into the vitreous body more frequently(12 cases in 41 and 2 in 40 respectively, p = 0.0007). Patients with severe non-proliferative DR tended to have reduced requirement for vitrectomyafter PLC compared with those having early proliferative DR (1 case of 40 and 6 of 41, p = 0.052).Conclusion: The above results suggest the necessity of early PLC in DM1 patients.Dmitriy Sergeevich AtarshchikovVladimir Yur'evich EvgrafovYury Evgen'evich BatmanovEndocrinology Research Centrearticlediabetic retinopathypanretinal laser coagulationtriamcinolonediabetes mellitusNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 13, Iss 1, Pp 112-115 (2010)
institution DOAJ
collection DOAJ
language EN
RU
topic diabetic retinopathy
panretinal laser coagulation
triamcinolone
diabetes mellitus
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle diabetic retinopathy
panretinal laser coagulation
triamcinolone
diabetes mellitus
Nutritional diseases. Deficiency diseases
RC620-627
Dmitriy Sergeevich Atarshchikov
Vladimir Yur'evich Evgrafov
Yury Evgen'evich Batmanov
Results of early panretinal laser coagulation in patients with type 1 diabetes mellitus
description Aim. To evaluate results of panretinal laser coagulation (PLC) for severe non-proliferative and early proliferetaive diabetic retinopathy (DR) in patientswith type 1 diabetes mellitus (DM1). Materials and methods. 58 patients with DM1 were observed. All of them were treated by panretinal laser coagulation after subtenon administrationof triamcinolone (40 mg) under ultrasonic control. Results. PLC at the stage of severe non-proliferative DR stabilized its development in 35% of the patients and caused its reverse development withresolution of oedema and intraretinal hemorrhage, normalization of vein diameter, and improvement of visual acuity in 30%. In 35% of these casesPLC caused neovascularization within 1.6?0.9 years after treatment. Reverse development of DR after PLC was documented in 46.3% cases withearly proliferative DR but stabilization of DR occurred rarer than in the previous group (14.6%) and hemorrhage into the vitreous body more frequently(12 cases in 41 and 2 in 40 respectively, p = 0.0007). Patients with severe non-proliferative DR tended to have reduced requirement for vitrectomyafter PLC compared with those having early proliferative DR (1 case of 40 and 6 of 41, p = 0.052).Conclusion: The above results suggest the necessity of early PLC in DM1 patients.
format article
author Dmitriy Sergeevich Atarshchikov
Vladimir Yur'evich Evgrafov
Yury Evgen'evich Batmanov
author_facet Dmitriy Sergeevich Atarshchikov
Vladimir Yur'evich Evgrafov
Yury Evgen'evich Batmanov
author_sort Dmitriy Sergeevich Atarshchikov
title Results of early panretinal laser coagulation in patients with type 1 diabetes mellitus
title_short Results of early panretinal laser coagulation in patients with type 1 diabetes mellitus
title_full Results of early panretinal laser coagulation in patients with type 1 diabetes mellitus
title_fullStr Results of early panretinal laser coagulation in patients with type 1 diabetes mellitus
title_full_unstemmed Results of early panretinal laser coagulation in patients with type 1 diabetes mellitus
title_sort results of early panretinal laser coagulation in patients with type 1 diabetes mellitus
publisher Endocrinology Research Centre
publishDate 2010
url https://doaj.org/article/45340d6bf79e49b5b1900d5b2ff1185a
work_keys_str_mv AT dmitriysergeevichatarshchikov resultsofearlypanretinallasercoagulationinpatientswithtype1diabetesmellitus
AT vladimiryurevichevgrafov resultsofearlypanretinallasercoagulationinpatientswithtype1diabetesmellitus
AT yuryevgenevichbatmanov resultsofearlypanretinallasercoagulationinpatientswithtype1diabetesmellitus
_version_ 1718429644146868224